PURPOSE: The primary objective of this study was to determine whether children with localized ependymoma experience a decline in verbal or visual-auditory learning after conformal radiation therapy (CRT). The secondary objective was to investigate the impact of age and select clinical factors on learning before and after treatment. METHODS AND MATERIALS: Learning in a sample of 71 patients with localized ependymoma was assessed with the California Verbal Learning Test (CVLT-C) and the Visual-Auditory Learning Test (VAL). Learning measures were administered before CRT, at 6 months, and then yearly for a total of 5 years. RESULTS: There was no significant decline on measures of verbal or visual-auditory learning after CRT; however, younger age, more surgeries, and cerebrospinal fluid shunting did predict lower scores at baseline. There were significant longitudinal effects (improved learning scores after treatment) among older children on the CVLT-C and children that did not receive pre-CRT chemotherapy on the VAL. CONCLUSION: There was no evidence of global decline in learning after CRT in children with localized ependymoma. Several important implications from the findings include the following: (1) identification of and differentiation among variables with transient vs. long-term effects on learning, (2) demonstration that children treated with chemotherapy before CRT had greater risk of adverse visual-auditory learning performance, and (3) establishment of baseline and serial assessment as critical in ascertaining necessary sensitivity and specificity for the detection of modest effects. Copyright 2010 Elsevier Inc. All rights reserved.
PURPOSE: The primary objective of this study was to determine whether children with localized ependymoma experience a decline in verbal or visual-auditory learning after conformal radiation therapy (CRT). The secondary objective was to investigate the impact of age and select clinical factors on learning before and after treatment. METHODS AND MATERIALS: Learning in a sample of 71 patients with localized ependymoma was assessed with the California Verbal Learning Test (CVLT-C) and the Visual-Auditory Learning Test (VAL). Learning measures were administered before CRT, at 6 months, and then yearly for a total of 5 years. RESULTS: There was no significant decline on measures of verbal or visual-auditory learning after CRT; however, younger age, more surgeries, and cerebrospinal fluid shunting did predict lower scores at baseline. There were significant longitudinal effects (improved learning scores after treatment) among older children on the CVLT-C and children that did not receive pre-CRT chemotherapy on the VAL. CONCLUSION: There was no evidence of global decline in learning after CRT in children with localized ependymoma. Several important implications from the findings include the following: (1) identification of and differentiation among variables with transient vs. long-term effects on learning, (2) demonstration that children treated with chemotherapy before CRT had greater risk of adverse visual-auditory learning performance, and (3) establishment of baseline and serial assessment as critical in ascertaining necessary sensitivity and specificity for the detection of modest effects. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: M Dennis; B J Spiegler; M C Obonsawin; B L Maria; C Cowell; H J Hoffman; E B Hendrick; R P Humphreys; J D Bailey; R M Ehrlich Journal: Neuropsychologia Date: 1992-03 Impact factor: 3.139
Authors: J Grill; V K Renaux; C Bulteau; D Viguier; C Levy-Piebois; C Sainte-Rose; G Dellatolas; M A Raquin; I Jambaqué; C Kalifa Journal: Int J Radiat Oncol Biol Phys Date: 1999-08-01 Impact factor: 7.038
Authors: D P Waber; N J Tarbell; D Fairclough; K Atmore; R Castro; P Isquith; F Lussier; I Romero; P J Carpenter; M Schiller Journal: J Clin Oncol Date: 1995-10 Impact factor: 44.544
Authors: Carol L Armstrong; Kunsang Gyato; Abdel W Awadalla; Robert Lustig; Zelig A Tochner Journal: Neuropsychol Rev Date: 2004-03 Impact factor: 7.444
Authors: Thomas E Merchant; Raymond K Mulhern; Matthew J Krasin; Larry E Kun; Tani Williams; Chenghong Li; Xiaoping Xiong; Raja B Khan; Robert H Lustig; Frederick A Boop; Robert A Sanford Journal: J Clin Oncol Date: 2004-08-01 Impact factor: 44.544
Authors: P K Duffner; M E Horowitz; J P Krischer; H S Friedman; P C Burger; M E Cohen; R A Sanford; R K Mulhern; H E James; C R Freeman Journal: N Engl J Med Date: 1993-06-17 Impact factor: 91.245
Authors: Matthew Koshy; Shayna Rich; Thomas E Merchant; Usama Mahmood; William F Regine; Young Kwok Journal: J Neurooncol Date: 2011-06-03 Impact factor: 4.130
Authors: Lisa M Jacola; Jason M Ashford; Wilburn E Reddick; John O Glass; Robert J Ogg; Thomas E Merchant; Heather M Conklin Journal: J Neurooncol Date: 2014-05-22 Impact factor: 4.130
Authors: Atmaram S Pai Panandiker; Thomas E Merchant; Chris Beltran; Shengjie Wu; Shelly Sharma; Frederick A Boop; Jesse J Jenkins; Kathleen J Helton; Karen D Wright; Alberto Broniscer; Larry E Kun; Amar Gajjar Journal: Int J Radiat Oncol Biol Phys Date: 2011-05-19 Impact factor: 7.038
Authors: Victoria W Willard; Heather M Conklin; Frederick A Boop; Shengjie Wu; Thomas E Merchant Journal: Int J Radiat Oncol Biol Phys Date: 2014-01-22 Impact factor: 7.038
Authors: Carmen Ares; Francesca Albertini; Martina Frei-Welte; Alessandra Bolsi; Michael A Grotzer; Gudrun Goitein; Damien C Weber Journal: J Neurooncol Date: 2016-03-05 Impact factor: 4.130